SEO URLwww.firestrike.ai/deals/pathai-roche-acquisition-2026-1
acquisitionAnnounced · May 8, 2026Digital Pathology and AI-powered technologySource · CredibleArticle · Factual
Roche acquires PathAI
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
PathAI
Boston, Massachusetts
Acquirer
Roche
Merger
Status
Announced
Roche agreed to acquire PathAI. Reported deal value: Undisclosed. Status: Announced. Sector: Digital Pathology and AI-powered technology. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-05-08. Figures and status may change as filings and press coverage update.
Boston Globe May 8, 2026 Roche has signed a deal to pay $ 750 million upfront for Boston -based PathAI , an acquisition by the Swiss pharmaceutical giant to speed up its use of artificial intelligence to help pathologists diagnose disease
Deal timeline
Announced
May 8, 2026 · statnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Digital Pathology and AI-powered technology. Figures and status may change as sources update.
Sources: statnews.com · Primary article · FireStrike proprietary index